Asthma Attack: Symptoms, Treatment, Monitoring & Red Flags

An asthma attack denotes an acute amplification of airway smooth‑muscle bronchoconstriction, mucosal edema, and mucus plugging layered on variable chronic type‑2 inflammation. Pathophysiology concentrates on expiratory flow limitation and air trapping leading to dynamic hyperinflation—a pattern read against each patient’s spirometry baseline, prior ED utilisation, inhaler literacy, trigger journal, comorbid cardiorespiratory disease, and—for overlap phenotypes—risk of hypercapnia if oxygen is unrestricted. When IgE‑mediated bronchospasm dominates with systemic allergic features, epinephrine takes primacy over bronchodilator reassurance alone.

Exacerbations range from increased home reliever reliance to critical hypoxemic failure. International evidence syntheses underscore prompt inhaled SABA titration, urgent systemic corticosteroids for moderate–severe attacks, controlled oxygen, waveform-quality SpO₂ scrutiny, and escalation when mental status or ventilation buckles. Chronic asthma optimisation between attacks is a different workflow; this page concentrates on time‑sensitive rescue care, monitoring density, and escalation language.

Severity strata drive site of care, observation frequency, need for continuous monitoring, bronchodilator stacking, and airway rescue readiness. Pair numbers with clinician gestalt—validated scores help, but cannot replace serial exams when patients fatigue between measurements.

*Interpret SpO₂ waveform quality alongside perfusion status; escalate when serial gases or bedside lactate patterns pair with escalating work of breathing—even before numbers cross historical cutoffs.

Symptoms escalate along the same inflammatory–bronchoconstrictive axis but individual phenotypes emphasize cough-predominant versus wheeze-predominant patterns; older adults may perceive dyspnea as fatigue or cite isolated chest tightness; children tachypnea without eloquent symptom reporting.

Typical features

• Progressive exertional dyspnea and accessory muscle recruitment with prolonged expiratory phase
• Diffuse polyphonic wheeze with hyperinflation percussion note (until extremes)
• Use of tripod posture when accessory muscles fatigue

Atypical or high-risk nuances

• Wheeze-absent severe bronchospasm in elderly/obese patients masking severity
• Triggers such as thunderstorms, aspirin/NSAID exposure suggesting specialist phenotyping downstream
• Coexisting pulmonary embolism risk—consider when pleuritic pain or unilateral-leg swelling coexist

Viral URIs—notably rhinoviruses—and seasonal allergens remain dominant precipitants, but clinician-facing risk stratification concentrates on inhaler adherence gaps, illicit substance inhalation, aspirin-exacerbated respiratory disease phenotype, hormonal flux (progesterone/dynamic asthma in pregnancy mandates obstetric co-management), NSAID dosing for musculoskeletal complaints, GERD interplay, thunderstorms/electrophile pollution episodes, occupational isocyanate or bakery flour exposures needing occupational health liaison, psychiatric comorbidity impairing inhaler mastery, obstructive sleep risk, and socioeconomic barriers delaying early presentation.

• Infection-mediated: Fever with focal consolidation cues steers stewardship toward antimicrobial pathways when bacterial pneumonia dominates.
• Cardiovascular overlap: Orthopnea, jugular venous distension, or disproportionate bilateral crackles raise heart failure probability—arrange bedside ultrasound/echocardiography per cardiology access.
• Iatrogenic/aggravators: non-selective beta blockers precipitating bronchospasm—medication reconciliation is prevention.

Triage merges history with serial objective measures that actually change bedside actions—prioritising pattern recognition (respiratory nursing assessment checklist discipline), complication screening only when warranted, deferring exhaustive laboratory panels until trajectory clarifies.

• Spirometry / pulmonary function testing schedule: defer detailed PFT confirmation until airway stabilization.
• Home peak flow competency: compare serial readings versus personal-best baselines ensuring proper technique hygiene.
• Chest radiography: pursue with focal signs, refractory hypoxemia, suspected pneumothorax, or alternative diagnosis uncertainty.
• Labs selectively: venous bicarbonate/lactate, blood gas stratification critical in severe exhaustion; eosinophil count helps biologic escalation planning later—not emergency therapy selection alone; CRP contextualises infection—not isolate wheeze diagnoses.
• Allergic airway crisis: coordinate intramuscular adrenaline first-line when anaphylactic features accompany bronchospasm—never substitute prolonged SABA stacks alone.

1. Assess airway & oxygenation: titrate nasal cannula masks or high-flow apparatus per bedside policy—mind hypercapnia-susceptible overlap phenotypes.
2. Deliver SABA urgently: repeat doses per bundled pathway; spacer coaching if MDI-first policy.
3. Add SAMA when indicated: scheduled ipratropium cycles for moderate–severe bundles where protocol stipulates.
4. Early systemic steroid: oral prednisolone when swallowing tolerated; IV methylprednisolone when vomiting dominates.
5. Observe trajectory: chart peak flow/SpO₂/RR trends after each bronchodilator cycle; escalate if clinical plateau persists.
6. Second-line pharmacology: consider IV magnesium sulfate; advanced ketamine or methylxanthine strategies stay critical-care governed.
7. Ventilation triggers: rising CO₂, refractory hypoxemia, inability to maintain minute ventilation despite maximal medical therapy ⇒ critical care airway support.

If attacks blur with longstanding COPD (asthma–COPD overlap), align steroid duration, oxygen prescribing, and antimicrobial decisions with infiltrate-guided bundles while never delaying bronchospasm reversal.

↔On a small screen, swipe or scroll sideways to see the full table.

Management balances rapid bronchodilation with beta-agonist toxicity monitoring—tremor, palpitations, hypokalemia especially when infusion therapy extends—and aerosol precautions when clustered nebuliser care occurs in cohort bays.

First-line interventions

• High-frequency SABA delivery with spacer coaching wherever clinical equipoise permits MDI programmes
• Early oral or intravenous systemic corticosteroids sized to exacerbation severity and absorption reliability
• Supplemental oxygen titrated to clinically prescribed saturation corridors—including cautious targets when retention phenotypes coexist

Second-line / critical-care adjuncts

• Scheduled ipratropium dosing when moderate–severe pathways combine antimuscarinic and beta-agonist stacks
• IV magnesium sulfate when institutional sedation staffing and infusion monitoring capacity align
• Prepare NIV/intubation when ventilation failure thresholds crossed—senior-led

Special populations

• Pregnancy: fetal monitoring collaboration; maintain oxygenation—treat bronchospasm aggressively because maternal hypoxia risks fetus more than short-course steroids when indicated.
• Older adults: cautious interpretation of “mild” symptoms; lower threshold for continuous monitoring and early HDU discussion.

• Observation cadence: severe patients warrant high-frequency vitals (often ≤30–60 min initially) until two consecutive improving trends—then step down per local policy.
• Handoffs: Communicate reliever count, last steroid time/route, SpO₂ trajectory, mental status, IV access, isolation requirements, and pending labs.
• Device education before discharge: reinforce MDI–spacer mastery and schedule pulmonary function laboratory follow-up when referral bandwidth exists.
• Failure criteria: rising oxygen requirement, dropping peak flow after initial bump, persistent inability to speak in full sentences, or nursing concern despite “stable” numbers—trigger senior review.
• Referral: specialist asthma/immunology or difficult-asthma clinics when recurrent admissions, ≥2 OCS bursts/year, or chronic high-dose steroid dependence.

• Barotrauma / pneumothorax from air trapping or ventilator strategies
• Respiratory acidosis with obtundation heralding intubation
• Arrhythmias / demand ischemia from hypoxia and catecholamine surges
• Steroid hyperglycemia—especially in known diabetes; coordinate sliding-scale or insulin plans
• Post-exacerbation mood disruption and PTSD-like hypervigilance—brief psychosocial screen before discharge

Between attacks clinicians emphasise ICS-containing controllers, spacer literacy, vaccinations, SMART/MART regimens aligned with formulary, allergen/smoke avoidance, pharmacist-led inhaler substitutions, referral to multidisciplinary difficult-asthma services when relapse remains frequent despite optimised maintenance therapy, leukotriene inhibitors or methylxanthines strictly under specialist pacing, occupational redeployment, and timely post-ED clinician review windows mirroring NHS 48‑hour stewardship messaging.

Most patients stabilize within hours to days once bronchodilator–steroid synergy engages; relapse risk concentrates in patients leaving with incomplete steroid courses, poor technique, unmanaged comorbidity, marginal housing, ongoing smoke exposure, or anxiety-driven hyperventilation mislabelled as bronchospasm. Document explicit return precautions and objective home monitoring thresholds where peak flow competency exists.

• Pair quantitative trends (HR/RR/SpO₂) with qualitative wording (“speech now two-word bursts”)—ED crowding hides nuance unless nursing charting stays specific.
• Keep language trauma-informed when patients fear masks or nebulisers—offer coaching and privacy.
• Use interpreter phones before consenting procedural sedation or BiPAP lest distress worsens airway resistance.
• Timestamp every bronchodilator round to prevent accidental stacking or accidental omission during shift change.

• Airway–breathing: speech, accessory muscles, paradoxical abdomen, percussion note, bilateral vs unilateral wheeze changes
• Circulation: BP trends, pulsus paradox suspicion, tachycardia vs beta-agonist effect
• Objective adjuncts: SpO₂ waveform quality, repeatable peak flow attempts, FiO₂ device match
• Therapeutics: steroid given? route/time; magnesium running? electrolytes checked if prolonged therapy?
• Deterioration triggers: rising CO₂, confusion, diminishing sounds—already verbalised in safety huddle?

• Inability to complete sentences while awake, lethargy, cyanosis or SpO₂ below target despite oxygen
• Home reliever repetitions exhausting maximum safe interval without plateau—especially if peak flow plunges under personal action-plan red zone
• First-ever severe bronchospasm or pregnancy with worsening respiratory distress—lower threshold

Align community advice with ambulance activation policies analogous to NHS 999 thresholds when deterioration occurs after maximal home reliever use.

Subjective tipping points

• Accessory muscle exhaustion or patient verbalising “something changed” amidst prior stability
• Acute alteration in awake state after therapy—especially post-sedation or post-op contexts

Objective escalation cues

• Rising PaCO₂ / falling pH on blood gas when obtained
• SpO₂ drift despite escalating FiO₂ or high-flow systems
• Lactate elevation with hypoperfusion pattern

Who to call & when

• Ward instability: escalate to senior medical clinician immediately; preload critical care liaison
• Concern for pneumothorax: urgent chest imaging / thoracic review per needle decompression readiness

Nursing stewardship spans aerosol optimisation, sedation readiness whenever intubation risk transitions from theoretical to plausible, carbohydrate surveillance when intravenous steroid bursts extend, spacer teaching, meticulous nebuliser hygiene documentation, behavioural health screening after frightening attacks, partnering with allied health for discharge bundles, coordinating interpreter access before informed consent conversations about non-invasive ventilation, and safeguarding medication reconciliation—including withdrawal of culprit beta blockers pending cardiology discourse.

Pre-treatment priorities

• Verify allergies, inhaler/device inventory at bedside, nicotine/vape exposures
• Eliminate needless exertion—bathroom passes only when stabilized

During treatment bursts

• Coach pursed-lip pacing only when not contraindicated by institutional policy vs dynamic hyperinflation physiology
• Monitor tremor versus new arrhythmias when continuous SABA infusions utilised

Post-stabilisation education

• Discuss trigger avoidance, spacer hygiene, vaccinations, inhaler reorder logistics
• Arrange pharmacist or respiratory therapist review plus written action plan duplication

These NCLEX-style clinical judgment practice items focus on the nursing priorities for this condition — recognise cues, escalate red flags, take safe action and evaluate outcomes (NCSBN Clinical Judgment Measurement Model) — through Priority FIRST, SATA, deterioration trends, multi-patient triage, ordered response, matrix matching and a compact cloze on the topic of the acute asthma exacerbation: severity stratification, oxygen / nebuliser / steroid bundle, IV magnesium and ICU intubation triggers.